Clinical Trial Update: A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Bimatoprost SR to selective laser trabeculoplasty in open-angle glaucoma or ocular hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost SR (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2022-02-23